Zobrazeno 1 - 10
of 141
pro vyhledávání: '"S, Spike"'
Publikováno v:
Frontiers in Virology, Vol 4 (2024)
The COVID-19 virus is a single-stranded virus from the Coronaviridae family and has a genome of about 29881 bp, which causes acute respiratory disease. One way of transmission of the COVID-19 virus is respiratory, which is the reason for the signific
Externí odkaz:
https://doaj.org/article/5d0a67c4e0514cb78bbea790f065e6be
Autor:
Mahmoud M. Berekaa
Publikováno v:
Frontiers in Bioscience-Elite, Vol 13, Iss 1, Pp 117-139 (2020)
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the human coronavirus (HCoV) family that targets the lower part of the respiratory tract and causes severe acute respiratory syndrom
Externí odkaz:
https://doaj.org/article/fca2cbcd7de646088a2ca4682ab44b55
Autor:
Olga I. Yarovaya, Dmitriy N. Shcherbakov, Sophia S. Borisevich, Anastasiya S. Sokolova, Maxim A. Gureev, Edward M. Khamitov, Nadezda B. Rudometova, Anastasiya V. Zybkina, Ekaterina D. Mordvinova, Anna V. Zaykovskaya, Artem D. Rogachev, Oleg V. Pyankov, Rinat A. Maksyutov, Nariman F. Salakhutdinov
Publikováno v:
Viruses, Vol 14, Iss 6, p 1295 (2022)
In the present work we studied the antiviral activity of the home library of monoterpenoid derivatives using the pseudoviral systems of our development, which have glycoproteins of the SARS-CoV-2 virus strains Wuhan and Delta on their surface. We fou
Externí odkaz:
https://doaj.org/article/0801fba33b9444c79b2014fcc3bb8a46
Autor:
Sophia S. Borisevich, Edward M. Khamitov, Maxim A. Gureev, Olga I. Yarovaya, Nadezhda B. Rudometova, Anastasiya V. Zybkina, Ekaterina D. Mordvinova, Dmitriy N. Shcherbakov, Rinat A. Maksyutov, Nariman F. Salakhutdinov
Publikováno v:
Viruses, Vol 14, Iss 1, p 119 (2022)
In this work, we evaluated the antiviral activity of Arbidol (Umifenovir) against SARS-CoV-2 using a pseudoviral system with the glycoprotein S of the SARS-CoV-2 virus on its surface. In order to search for binding sites to protein S of the virus, we
Externí odkaz:
https://doaj.org/article/96324727f17f40e2b9a078db23748bfe
Autor:
Andrés Antón, Candela Fernández-Naval, Iria Arrese-Muñoz, Juliana Esperalba, Mónica Martínez-Gallo, Ricardo Pujol-Borrell, Victoria Cardona, Tomás Pumarola, Moises Labrador-Horrillo, Victor Sanda, Manuel Hernández-González
Publikováno v:
Medicina Clinica
It is crucial to assess the levels of protection generated by natural infection or SARS-CoV-2 vaccines, mainly in individuals professionally exposed and in vulnerable groups. Measuring T-cell responses may complement antibody tests currently in use a
Autor:
Kai Wu, Carole Henry, Charis Palandjian, Sarah O’Connell, Angela Woods, Darin K. Edwards, Anna Hill, Hamilton Bennett, Naveen Nunna, Elisabeth Narayanan, Samantha Falcone, Matthew A. Koch, Andrea Carfi, Robert A. Seder, Diana Lee, Guillaume Stewart-Jones, LingZhi Ma, Barney S. Graham, Angela Choi, Tonya M. Colpitts, Kizzmekia S. Corbett, Adrian B. McDermott, Sayda Elbashir, Julian Quinones, Hardik Jani
Publikováno v:
bioRxiv
Vaccine
Vaccine
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of a global pandemic that has led to more than 2.8 million deaths worldwide. Safe and effective vaccines are now available, including Moderna’s COVID-19 vaccine (mR
Publikováno v:
Clinica Chimica Acta; International Journal of Clinical Chemistry
Background and aims Long-term kinetics of anti-RBD IgG and neutralizing antibodies were analyzed in a cohort of COVID-19 naive health care workers (HCW) undergoing SARS-CoV-2 vaccination. Methods An anti-RBD IgG immunoassay and a surrogate virus neut
Autor:
Eric Destexhe, Sarah Paris-Robidas, Charlotte Dubé, Nathalie Landry, Sonia Trépanier, Iryna Primakova, Brian J. Ward
Publikováno v:
Reproductive Toxicology (Elmsford, N.y.)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection resulting in the coronavirus disease 2019 (COVID-19) has afflicted tens of millions of people in a worldwide pandemic. A recently developed recombinant Plant-Derived Virus-Like Pa
Autor:
Jin Gyu Jung, Sunghyun Kim, Bum Soo Kim, Anca Streinu-Cercel, Oana Săndulescu, Da Bee Jeon, Adrian Streinu-Cercel, Seul Gi Lee, Sang Joon Lee, Yeon Sook Kim, Yeo Jin Lee, Jin Yong Kim, Yeon Mi Lee, Min Kyung Kim, Jae-Hyeong Park, Jang Hee Hong, Jeong Eun Park, Young Rock Jang, Na Hyun Jung
Publikováno v:
Clinical Therapeutics
PURPOSE: Neutralizing antibodies can reduce SARS-CoV-2 cellular entry, viral titers, and pathologic damage. CT-P59 (regdanvimab), a SARS-CoV-2 neutralizing monoclonal antibody, was examined in 2 randomized, double-blind, placebo-controlled, single as
Autor:
Maurizio Federico
Publikováno v:
Cytokine & Growth Factor Reviews
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has given rise to the urgent need for vaccines and therapeutic interventions to address the spread of the SARS-CoV-2 virus. SARS-CoV-2 vaccines in development, and those being